Thursday, December 1, 2022
Home Tags Oral

Tag: oral

Bio Farma secures multi-year Purchase Contract from UNICEF for its novel...

0
BANDUNG, INDONESIA, Oct 2, 2022 - (ACN Newswire) - PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export...

New Data for Shionogi’s COVID-19 Once-Daily Oral Antiviral S-217622 Show Rapid...

0
Shionogi & Co., Ltd. (hereafter "Shionogi") today announced new results from two late-breaking presentations of S-217622 at the 32nd European Congress of Clinical...

Evelo Biosciences Presents Late-Breaking Oral Abstract on Data from Phase 2...

0
CAMBRIDGE, Mass., March 26, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. EVLO, a clinical stage biotechnology company developing SINTAX™ medicines as...

Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacit… –...

0
HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir...

Oral Antivirals Market Business Analysis, New Innovations, Shares and Forecast till...

0
The study on the global Oral Antivirals market published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the...

Sleep Apnea Oral Appliances Market worth 482.5 Million USD by 2023...

0
Pune, India, 2021-Jul-15 — /EPR Network/ — The global sleep apnea oral appliances market is expected to register a CAGR of 15.7% during the...

Paratek Pharmaceuticals Announces FDA Approval of NUZYRA® (omadacycline) Oral Only Dosing...

0
- Oral-only dosing for the Treatment of CABP Expands the Commercial Opportunity for Primary Care Promotion - Primary Care Market Opportunity for...

BioCryst Receives UK Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy...

0
RESEARCH TRIANGLE PARK, N.C., May 12, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United Kingdom’s...

Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation...

0
Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a +1.29 point mean change in NIS, was more favorable than expected...

Innovation Pharma Announces Brilacidin Abstract Accepted for Oral Presentation at the...

0
Growing body of in vitro data support Brilacidin’s potential as a broad-spectrum inhibitor of virusesBrilacidin is currently undergoing Phase 2 clinical testing against...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News